Cynthia Siu
Overview
Explore the profile of Cynthia Siu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Goldberg J, Siu C, Tocco M, Pikalov A, Loebel A
J Clin Psychiatry
. 2023 Jun;
84(4).
PMID: 37339360
To assess the effects of lurasidone on anxiety symptoms and sleep disruption, and their moderating and mediating roles on treatment response in bipolar depression. This post hoc analysis included pooled...
2.
Singh M, Siu C, Tocco M, Pikalov A, Loebel A
Curr Neuropharmacol
. 2022 Sep;
21(6):1393-1404.
PMID: 36173066
Background: The presence of mixed (subsyndromal hypomanic) symptoms may influence treatment outcomes in pediatric bipolar depression. This post-hoc analysis investigated "bridge" symptoms that have cross-sectional and predictive associations with depressive...
3.
Goldberg J, Siu C, Mao Y, Tsai J, Pikalov A, Calabrese J, et al.
J Affect Disord
. 2020 Oct;
277:1045-1054.
PMID: 33065813
Background: To investigate the symptom network structure of major depressive disorder (MDD) with mixed features and implications for treatment. Methods: In this post-hoc analysis of a previously reported randomized trial,...
4.
Singh M, Pikalov A, Siu C, Tocco M, Loebel A
J Child Adolesc Psychopharmacol
. 2020 May;
30(10):590-598.
PMID: 32392455
To evaluate the efficacy and safety of lurasidone in the treatment of children and adolescents with bipolar depression presenting with mixed (subsyndromal hypomanic) features. Patients, 10-17 years of age, with...
5.
Raison C, Siu C, Pikalov A, Tocco M, Loebel A
Brain Behav Immun
. 2019 Dec;
84:269-274.
PMID: 31857217
This study sought to investigate associations between levels of high-sensitivity c-reactive protein (hsCRP) prior to treatment and change in depressive symptoms and cognition in a short-term, double-blind, placebo-controlled study of...
6.
Thomas D, Clark N, Turner D, Siu C, Halliday T, Hannon B, et al.
Am J Clin Nutr
. 2019 Sep;
111(2):256-265.
PMID: 31552422
Background: Regression to the mean (RTM) is a statistical phenomenon where initial measurements of a variable in a nonrandom sample at the extreme ends of a distribution tend to be...
7.
Takeuchi H, Siu C, Remington G, Fervaha G, Zipursky R, Foussias G, et al.
Neuropsychopharmacology
. 2018 Dec;
44(6):1036-1042.
PMID: 30514883
Although some studies have suggested that relapse may be associated with antipsychotic treatment resistance in schizophrenia, the number and quality of studies is limited. The current analysis included patients with...
8.
Hannon B, Thomas D, Siu C, Allison D
Br J Nutr
. 2018 Aug;
120(8):958-959.
PMID: 30160224
No abstract available.
9.
Raison C, Pikalov A, Siu C, Tsai J, Koblan K, Loebel A
Brain Behav Immun
. 2018 Aug;
73:717-724.
PMID: 30102967
Prior studies suggest that the inflammatory biomarker c-reactive protein (CRP) holds promise for predicting antidepressant response in patients with major depressive disorder. The objective of this study was to evaluate...
10.
Kahathuduwa C, Thomas D, Siu C, Allison D
Diabetes Obes Metab
. 2018 Apr;
20(8):2039-2040.
PMID: 29660244
No abstract available.